|
|
||||||||
CUTTING EDGE |



*
Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; and
Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation, Osaka, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Initial host defense against bacterial infection is executed by innate immunity, characterized by the use of germline-encoded receptors for pathogen recognition (2). In Drosophila, Toll family plays a key role in antifungal and antibacterial host defense (3). Recently, mammalian homologues of Toll, designated as Toll-like receptors (TLRs),3 were discovered (4, 5, 6). Each TLR is a type I transmembrane receptor possessing an extracellular leucine-rich repeat and a cytoplasmic Toll/IL-1 receptor homology domain. They are expected to act as pattern recognition receptors, which distinguish pathogen-associated molecular patterns, such as LPS, peptidoglycan (PGN), and lipoprotein (2). Among TLR family members, both TLR2 and TLR4 have been shown to recognize bacterial components. A mutation in the Tlr4 gene is responsible for the phenotype of the C3H/HeJ mouse strain, which is unresponsiveness to LPS, a component of the outer membrane of Gram-negative bacteria (7). Targeted disruption of the Tlr4 gene resulted in abrogation of responses to LPS and lipoteichoic acid (8, 9). In contrast, TLR2 is implicated in the recognition of Gram-positive bacterial components, bacterial lipoproteins, and zymosan (10, 11, 12, 13, 14, 15). TLR2-deficient mice displayed impaired cytokine production in response to Staphylococcus aureus PGN preparation and mycoplasmal lipopeptide (9, 16).
MyD88 is a cytoplasmic adaptor molecule essential for the signaling of
IL-1R/TLR family. Ligand binding to IL-1R/TLR family results in the
recruitment of MyD88 to Toll/IL-1 receptor domains of receptors, which
bridges the signal to IL-1R-associated kinase. Ultimately, the
activation of a transcription factor NF-
B occurs and permits the
transactivation of proinflammatory cytokine genes (17, 18). We have generated MyD88-deficient mice and shown that MyD88
is essential for cellular responses to IL-1, IL-18, and many bacterial
cell wall components such as LPS, PGN, and lipopeptide
(19, 20, 21).
C3H/HeJ mice are known to be highly sensitive to infection with Gram-negative bacteria, owing to the failure of LPS recognition (22). Although TLR2 participates in the recognition of Gram-positive bacteria, a substantial role of TLR2 in host defense against Gram-positive bacteria was still unclear. In the present study, we investigated the role of TLR2 and MyD88 in S. aureus infection using mutant mice deficient in these molecules.
| Materials and Methods |
|---|
|
|
|---|
The mutant mouse (F2 interbred from 129/Ola x C57BL/6) strains deficient in TLR2, TLR4, or MyD88 were generated by gene targeting as described previously (8, 9, 19). MyD88-deficient mice were backcrossed eight times with C57BL/6 mice. For S. aureus infection, groups of TLR2-deficient mice and wild-type littermates or MyD88-deficient mice (C57BL/6 background) and wild-type littermates were used. Age-matched groups of wild-type, TLR2-, TLR4-, and MyD88-deficient mice were used for the other experiment.
Bacteria and infection
S. aureus 834 strain (gift from A. Nakane, Hirosaki University, Japan) was classified as coagulase type II, produced toxic shock syndrome toxin I and methicillin resistant (23), and it was prepared as described previously (23, 24). In brief, bacteria were cultured on trypticase soy agar (Becton Dickinson, Sparks, MD), inoculated with trypticase soy broth, and incubated for 15 h at 37°C. The bacteria were collected and resuspended by PBS. The concentration of resuspended cells was adjusted spectrophotometrically at 550 nm. Mice were given i.v. injections of 0.2 ml of bacterial solution containing 1 x 107 CFU of viable S. aureus and their survival was monitored for up to 14 days. S. aureus suspension (1 x 109 CFU/ml in PBS) was boiled for 30 min and used as heat-killed S. aureus.
Determination of the number of bacteria in blood and organs
Mice were given 1 x 107 CFU or 1 x 106 CFU of S. aureus as an i.v. infection, and they were killed 1, 2, or 5 days later. Spleens and kidneys were dissected, homogenized, and diluted in 10-fold steps in sterile water containing 0.5% Triton X-100 (Nacalai Tesque, Kyoto, Japan). Blood was also diluted in water containing 0.5% Triton X-100. Bacterial CFU was determined by plating each dilution on trypticase soy agar and was cultured for 24 h at 37°C.
Preparation of peritoneal macrophages
Mice were i.p. injected with 2 ml of 4% thioglycolate (Difco,
Detroit, MI). Three days later, peritoneal exudate cells were isolated
from the peritoneal cavity by washing with ice-cold HBSS (Life
Technologies, Rockville, MD). Cells were cultured for 2 h and
washed with HBSS to remove nonadherent cells. Adherent monolayer cells
were used as peritoneal macrophages. Peritoneal macrophages (5 x
105/ml) were cultured in RPMI 1640 medium
(Nacalai Tesque) supplemented with 10% FCS and stimulated with 1
x 107 CFU/ml of heat-killed S. aureus
for 24 h. Concentration of TNF-
in culture supernatant was
determined by ELISA (Genzyme Techne, Minneapolis, MN) and IL-6
concentration was also measured by ELISA (Endogen, Boston,
MA).
Statistical analysis
Kaplan-Meier plots were conducted and the log rank test was used to test the differences in the survival between wild-type and TLR2-deficient or MyD88-deificient mice. The significances of the difference between the groups in the numbers of bacteria and cytokine concentrations were tested using Mann-Whitney U test.
| Results |
|---|
|
|
|---|
We have previously shown that TLR2 is required for the recognition
of PGN from S. aureus. Moreover, TLR2-deficient macrophages
did not produce TNF-
in response to cell wall preparation from
S. aureus (9). To evaluate the in vivo role of
TLR2 against S. aureus infection, wild-type and
TLR2-deficient mice were infected i.v. with 1 x
107 CFU of S. aureus and their
survival was monitored. As shown in Fig. 1
, all wild-type mice survived for 8 days
after S. aureus inoculation and 60% survived on day 14. In
contrast, about 80% of TLR2-deficient mice succumbed to S.
aureus and died within 8 days, and only 10% survived on day 14
(p < 0.03). However, when a low dose (1
x 106 CFU) of S. aureus was
administered in the mice, the survival was not altered between
wild-type and TLR2-deficient mice (data not shown). To investigate
whether this susceptibility was the result of altered bacterial
distribution and growth in vivo, the bacterial numbers in the blood,
spleen, and kidney of mice were determined at 1 and 2 days after 1
x 107 CFU of S. aureus infection. At
both 1 and 2 days, the number of S. aureus in the blood and
kidney were higher in TLR2-deficient mice, consistent with high
morbidity and mortality of TLR2-deficient mice after infection with
S. aureus (Fig. 2
A). When the mice were
inoculated with 1 x 106 CFU of S.
aureus, a statistically significant difference was not observed in
the bacterial numbers between wild-type and TLR2-deficient organs at
both 2 and 5 days after inoculum (Fig. 2
B).
|
|
MyD88 is an adaptor molecule essential for the signaling of the
IL-1R/TLR family. We have previously shown that MyD88-deficient mice
lacked responsiveness to IL-1, IL-18, and LPS (19, 20).
S. aureus PGN-induced TNF-
production was also abrogated
in MyD88-deficient macrophages, indicating the role of MyD88 in
anti-Gram-positive bacterial host defense (21).
Therefore, we infected MyD88-deficient mice with S. aureus
and monitored their survival. After inoculation with 1 x
107 S. aureus, all MyD88-deficient
mice succumbed to infection and died within 5 days, whereas 80% of
wild-type mice survived for 14 days (p <
0.0003,Fig. 3
). MyD88-deficient mice died
more rapidly than TLR2-deficient mice. Next, the number of bacterial
cells in the blood, spleen, and kidney were determined at 1 day of
1 x 107 CFU S. aureus
infection. Bacterial numbers in the blood and kidney were increased
in MyD88-deficient mice compared with wild-type mice (Fig. 4
A). Even when the mice were
inoculated with a lower dose of bacteria (1 x
106 CFU), the bacterial numbers in the organs
from MyD88-deficient mice were significantly higher than those from
wild-type mice (Fig. 4
B). These results indicate that
MyD88-deficient mice are more susceptible to S. aureus
infection than TLR2-deficient mice.
|
|
Furthermore, we examined the responsiveness of peritoneal
macrophages from wild-type, TLR2-, and MyD88-deficient mice to
heat-killed S. aureus. Thioglycolate-elicited peritoneal
macrophages were cultured in the presence of 1 x
107 CFU/ml of S. aureus for 24 h,
and concentrations of TNF-
and IL-6 in culture supernatant were
measured. Macrophages from wild-type and TLR4-deficient mice produced
almost the same amount of TNF-
in response to heat-killed S.
aureus. TLR2-deficient macrophages produced a reduced, but
significant level of TNF-
. In contrast, MyD88-deficient macrophages
did not produce any detectable TNF-
(Fig. 5
A). IL-6 production in
response to S. aureus was also reduced in TLR2-deficient
macrophages and abrogated in MyD88-deficient macrophages (Fig. 5
B).
|
| Discussion |
|---|
|
|
|---|
MyD88-deficient mice were also highly susceptible to S. aureus infection and they were more susceptible to infection than TLR2-deficient mice. We have shown that MyD88-deficient mice display the defective response to many bacterial components and IL-1 family cytokines such as IL-1 and IL-18 (19). Both severely impaired bacterial recognition and failure of signaling mediated by IL-1 family cytokines may contribute to the susceptibility of MyD88-deficient mice to infection.
We have previously shown that S. aureus cell wall-mediated
TNF-
production was fully TLR2 dependent (9).
Therefore, it was surprising that the production of
proinflammatory cytokine was induced in response to heat-killed
S. aureus in TLR2-deficient macrophages, although the level
was reduced compared with that in wild-type macrophages. In contrast,
bacteria-mediated TNF-
production was abrogated in MyD88-deficient
cells. Although TLR4-deficient macrophages displayed impaired
responsiveness to Gram-positive lipoteichoic acids,
TLR4-deficient macrophages re-sponded to heat-killed S.
aureus to the same extent as wild-type cells, indicating that
lipoteichoic acid on S. aureus cell surfaces may not
significantly contribute to cellular activations. These results suggest
that S. aureus is recognized not only by TLR2, but also by
other TLR/IL-1R family members except for TLR4. A previous report
demonstrated that the treatment with anti-TNF-
Ab to mice after
inoculation of S. aureus increased the death rate
(23). Our results also indicate the correlation between
the S. aureus-induced TNF-
production and the resistance
of mice to the infection.
Taken together, innate recognition of bacteria by TLR family members is quite important for eliminating invading bacteria. Particularly, TLR2 plays a crucial role in host defense against extracellular growing Gram-positive bacteria. Similarly, high mortality after S. aureus infection and complete abrogation of proinflammatory cytokine secretion in MyD88-deficient mice shows an essential role of MyD88 in resistance to Gram-positive bacterial infection.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Shizuo Akira, Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan. ![]()
3 Abbreviations used in this paper: TLR, Toll-like receptor; PGN, peptidoglycan. ![]()
Received for publication May 31, 2000. Accepted for publication September 13, 2000.
| References |
|---|
|
|
|---|
B and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187:2097.This article has been cited by other articles:
![]() |
B. B. Mishra, U. M. Gundra, K. Wong, and J. M. Teale MyD88-Deficient Mice Exhibit Decreased Parasite-Induced Immune Responses but Reduced Disease Severity in a Murine Model of Neurocysticercosis Infect. Immun., December 1, 2009; 77(12): 5369 - 5379. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sasaki, M. Ogasawara, T. Sekiguchi, S. Kusumoto, and H. Satake Toll-like Receptors of the Ascidian Ciona intestinalis: PROTOTYPES WITH HYBRID FUNCTIONALITIES OF VERTEBRATE TOLL-LIKE RECEPTORS J. Biol. Chem., October 2, 2009; 284(40): 27336 - 27343. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Munoz-Planillo, L. Franchi, L. S. Miller, and G. Nunez A Critical Role for Hemolysins and Bacterial Lipoproteins in Staphylococcus aureus-Induced Activation of the Nlrp3 Inflammasome J. Immunol., September 15, 2009; 183(6): 3942 - 3948. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Cheng, C.-Y. Wang, W.-C. Huang, C.-C. Tsai, C.-L. Chen, C.-F. Shen, C.-Y. Chi, and C.-F. Lin Staphylococcus aureus Induces Microglial Inflammation via a Glycogen Synthase Kinase 3{beta}-Regulated Pathway Infect. Immun., September 1, 2009; 77(9): 4002 - 4008. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Chang, W.-C. Kao, W.-Y. Wang, W.-Y. Wang, R.-B. Yang, and K. Peck Identification and characterization of oligonucleotides that inhibit Toll-like receptor 2-associated immune responses FASEB J, September 1, 2009; 23(9): 3078 - 3088. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chamorro, J. J. Garcia-Vallejo, W. W. J. Unger, R. J. Fernandes, S. C. M. Bruijns, S. Laban, B. O. Roep, B. A. 't Hart, and Y. van Kooyk TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program J. Immunol., September 1, 2009; 183(5): 2984 - 2994. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chassin, M. Picardeau, J.-M. Goujon, P. Bourhy, N. Quellard, S. Darche, E. Badell, M. F. d'Andon, N. Winter, S. Lacroix-Lamande, et al. TLR4- and TLR2-Mediated B Cell Responses Control the Clearance of the Bacterial Pathogen, Leptospira interrogans J. Immunol., August 15, 2009; 183(4): 2669 - 2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hruz, A. S. Zinkernagel, G. Jenikova, G. J. Botwin, J.-P. Hugot, M. Karin, V. Nizet, and L. Eckmann NOD2 contributes to cutaneous defense against Staphylococcus aureus through {alpha}-toxin-dependent innate immune activation PNAS, August 4, 2009; 106(31): 12873 - 12878. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Slack, S. Hapfelmeier, B. Stecher, Y. Velykoredko, M. Stoel, M. A. E. Lawson, M. B. Geuking, B. Beutler, T. F. Tedder, W.-D. Hardt, et al. Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism Science, July 31, 2009; 325(5940): 617 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Han, H. Yu, C. Tian, S. Li, M. R. Jacobs, C. Benedict-Alderfer, and Q. Y. Zheng Role for Toll-Like Receptor 2 in the Immune Response to Streptococcus pneumoniae Infection in Mouse Otitis Media Infect. Immun., July 1, 2009; 77(7): 3100 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Minegishi, M. Saito, M. Nagasawa, H. Takada, T. Hara, S. Tsuchiya, K. Agematsu, M. Yamada, N. Kawamura, T. Ariga, et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome J. Exp. Med., June 8, 2009; 206(6): 1291 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kenzel, S. Santos-Sierra, S. D. Deshmukh, I. Moeller, B. Ergin, K. A. Fitzgerald, E. Lien, S. Akira, D. T. Golenbock, and P. Henneke Role of p38 and Early Growth Response Factor 1 in the Macrophage Response to Group B Streptococcus Infect. Immun., June 1, 2009; 77(6): 2474 - 2481. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmaler, N. J. Jann, F. Ferracin, L. Z. Landolt, L. Biswas, F. Gotz, and R. Landmann Lipoproteins in Staphylococcus aureus Mediate Inflammation by TLR2 and Iron-Dependent Growth In Vivo J. Immunol., June 1, 2009; 182(11): 7110 - 7118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Nichols, A. L. Aldrich, M. M. Mariani, D. Vidlak, N. Esen, and T. Kielian TLR2 Deficiency Leads to Increased Th17 Infiltrates in Experimental Brain Abscesses J. Immunol., June 1, 2009; 182(11): 7119 - 7130. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. J. O'Neill, C. E. Bryant, and S. L. Doyle Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer Pharmacol. Rev., June 1, 2009; 61(2): 177 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Mogensen Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses Clin. Microbiol. Rev., April 1, 2009; 22(2): 240 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Puliti, S. Uematsu, S. Akira, F. Bistoni, and L. Tissi Toll-Like Receptor 2 Deficiency Is Associated with Enhanced Severity of Group B Streptococcal Disease Infect. Immun., April 1, 2009; 77(4): 1524 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Amiel, A. Alonso, S. Uematsu, S. Akira, M. E. Poynter, and B. Berwin Pivotal Advance: Toll-like receptor regulation of scavenger receptor-A-mediated phagocytosis J. Leukoc. Biol., April 1, 2009; 85(4): 595 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kurokawa, H. Lee, K.-B. Roh, M. Asanuma, Y. S. Kim, H. Nakayama, A. Shiratsuchi, Y. Choi, O. Takeuchi, H. J. Kang, et al. The Triacylated ATP Binding Cluster Transporter Substrate-binding Lipoprotein of Staphylococcus aureus Functions as a Native Ligand for Toll-like Receptor 2 J. Biol. Chem., March 27, 2009; 284(13): 8406 - 8411. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Alves-Filho, A. Freitas, F. O. Souto, F. Spiller, H. Paula-Neto, J. S. Silva, R. T. Gazzinelli, M. M. Teixeira, S. H. Ferreira, and F. Q. Cunha Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis PNAS, March 10, 2009; 106(10): 4018 - 4023. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Roger, C. Froidevaux, D. Le Roy, M. K. Reymond, A.-L. Chanson, D. Mauri, K. Burns, B. M. Riederer, S. Akira, and T. Calandra Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4 PNAS, February 17, 2009; 106(7): 2348 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Sorensen, L. S. Reinert, L. Malmgaard, C. Bartholdy, A. R. Thomsen, and S. R. Paludan TLR2 and TLR9 Synergistically Control Herpes Simplex Virus Infection in the Brain J. Immunol., December 15, 2008; 181(12): 8604 - 8612. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rocha-de-Souza, B. Berent-Maoz, D. Mankuta, A. E. Moses, and F. Levi-Schaffer Human Mast Cell Activation by Staphylococcus aureus: Interleukin-8 and Tumor Necrosis Factor Alpha Release and the Role of Toll-Like Receptor 2 and CD48 Molecules Infect. Immun., October 1, 2008; 76(10): 4489 - 4497. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miettinen, V. Veckman, S. Latvala, T. Sareneva, S. Matikainen, and I. Julkunen Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll-like receptor (TLR) gene expression in human primary macrophages J. Leukoc. Biol., October 1, 2008; 84(4): 1092 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sukhumavasi, C. E. Egan, A. L. Warren, G. A. Taylor, B. A. Fox, D. J. Bzik, and E. Y. Denkers TLR Adaptor MyD88 Is Essential for Pathogen Control during Oral Toxoplasma gondii Infection but Not Adaptive Immunity Induced by a Vaccine Strain of the Parasite J. Immunol., September 1, 2008; 181(5): 3464 - 3473. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hussain, N. Nasreen, Y. Lai, B. F. Bellew, V. B. Antony, and K. A. Mohammed Innate immune responses in murine pleural mesothelial cells: Toll-like receptor-2 dependent induction of {beta}-defensin-2 by staphylococcal peptidoglycan Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L461 - L470. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. von Bernuth, C. Picard, Z. Jin, R. Pankla, H. Xiao, C.-L. Ku, M. Chrabieh, I. B. Mustapha, P. Ghandil, Y. Camcioglu, et al. Pyogenic Bacterial Infections in Humans with MyD88 Deficiency Science, August 1, 2008; 321(5889): 691 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Piccini, S. Carta, S. Tassi, D. Lasiglie, G. Fossati, and A. Rubartelli ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1{beta} and IL-18 secretion in an autocrine way PNAS, June 10, 2008; 105(23): 8067 - 8072. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. S. Shin, R. R. Isberg, S. Akira, S. Uematsu, A. K. Behera, and L. T. Hu Distinct Roles for MyD88 and Toll-Like Receptors 2, 5, and 9 in Phagocytosis of Borrelia burgdorferi and Cytokine Induction Infect. Immun., June 1, 2008; 76(6): 2341 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pang, D. Winn, R. Johnson, W. Hong, S. West-Barnette, N. Kock, and W. E. Swords Lipooligosaccharides Containing Phosphorylcholine Delay Pulmonary Clearance of Nontypeable Haemophilus influenzae Infect. Immun., May 1, 2008; 76(5): 2037 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Nance, A.-K. Yi, F. C. Re, and E. A. Fitzpatrick MyD88 is necessary for neutrophil recruitment in hypersensitivity pneumonitis J. Leukoc. Biol., May 1, 2008; 83(5): 1207 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lampropoulou, K. Hoehlig, T. Roch, P. Neves, E. C. Gomez, C. H. Sweenie, Y. Hao, A. A. Freitas, U. Steinhoff, S. M. Anderton, et al. TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity J. Immunol., April 1, 2008; 180(7): 4763 - 4773. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leendertse, R. J. L. Willems, I. A. J. Giebelen, P. S. van den Pangaart, W. J. Wiersinga, A. F. de Vos, S. Florquin, M. J. M. Bonten, and T. van der Poll TLR2-Dependent MyD88 Signaling Contributes to Early Host Defense in Murine Enterococcus faecium Peritonitis J. Immunol., April 1, 2008; 180(7): 4865 - 4874. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Koga and G. Mor Review Article: Expression and Function of Toll-Like Receptors at the Maternal--Fetal Interface Reproductive Sciences, March 1, 2008; 15(3): 231 - 242. [Abstract] [PDF] |
||||
![]() |
W.K. E. Ip, K. Takahashi, K. J. Moore, L. M. Stuart, and R. A. B. Ezekowitz Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome J. Exp. Med., January 21, 2008; 205(1): 169 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Seo, S. M. Michalek, and M. H. Nahm Lipoteichoic Acid Is Important in Innate Immune Responses to Gram-Positive Bacteria Infect. Immun., January 1, 2008; 76(1): 206 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Stenzel, S. Soltek, M. Sanchez-Ruiz, S. Akira, H. Miletic, D. Schluter, and M. Deckert Both TLR2 and TLR4 Are Required for the Effective Immune Response in Staphylococcus aureus-Induced Experimental Murine Brain Abscess Am. J. Pathol., January 1, 2008; 172(1): 132 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Wisse, K. Ogimoto, J. Tang, M. K. Harris Jr., E. W. Raines, and M. W. Schwartz Evidence that Lipopolysaccharide-Induced Anorexia Depends upon Central, Rather than Peripheral, Inflammatory Signals Endocrinology, November 1, 2007; 148(11): 5230 - 5237. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Haden, H. B. Suliman, M. S. Carraway, K. E. Welty-Wolf, A. S. Ali, H. Shitara, H. Yonekawa, and C. A. Piantadosi Mitochondrial Biogenesis Restores Oxidative Metabolism during Staphylococcus aureus Sepsis Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 768 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Ku, H. von Bernuth, C. Picard, S.-Y. Zhang, H.-H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al. Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity J. Exp. Med., October 1, 2007; 204(10): 2407 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Csoka, Z. H. Nemeth, L. Virag, P. Gergely, S. J. Leibovich, P. Pacher, C.-X. Sun, M. R. Blackburn, E. S. Vizi, E. A. Deitch, et al. A2A adenosine receptors and C/EBP{beta} are crucially required for IL-10 production by macrophages exposed to Escherichia coli Blood, October 1, 2007; 110(7): 2685 - 2695. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cole, K. A. Shirey, E. Barry, A. Santiago, P. Rallabhandi, K. L. Elkins, A. C. Puche, S. M. Michalek, and S. N. Vogel Toll-Like Receptor 2-Mediated Signaling Requirements for Francisella tularensis Live Vaccine Strain Infection of Murine Macrophages Infect. Immun., August 1, 2007; 75(8): 4127 - 4137. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Auerbuch and R. R. Isberg Growth of Yersinia pseudotuberculosis in Mice Occurs Independently of Toll-Like Receptor 2 Expression and Induction of Interleukin-10 Infect. Immun., July 1, 2007; 75(7): 3561 - 3570. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Genestier, M. Taillardet, P. Mondiere, H. Gheit, C. Bella, and T. Defrance TLR Agonists Selectively Promote Terminal Plasma Cell Differentiation of B Cell Subsets Specialized in Thymus-Independent Responses J. Immunol., June 15, 2007; 178(12): 7779 - 7786. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kim, M. A. Kim, I.-H. Cho, M. S. Kim, S. Lee, E.-K. Jo, S.-Y. Choi, K. Park, J. S. Kim, S. Akira, et al. A Critical Role of Toll-like Receptor 2 in Nerve Injury-induced Spinal Cord Glial Cell Activation and Pain Hypersensitivity J. Biol. Chem., May 18, 2007; 282(20): 14975 - 14983. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Hoffmann, J. S. Braun, D. Becker, A. Halle, D. Freyer, E. Dagand, S. Lehnardt, and J. R. Weber TLR2 Mediates Neuroinflammation and Neuronal Damage J. Immunol., May 15, 2007; 178(10): 6476 - 6481. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chaudhuri, M. K. B. Whyte, and I. Sabroe Reducing the Toll of Inflammatory Lung Disease Chest, May 1, 2007; 131(5): 1550 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Dessing, K. F. van der Sluijs, S. Florquin, S. Akira, and T. van der Poll Toll-Like Receptor 2 Does Not Contribute to Host Response during Postinfluenza Pneumococcal Pneumonia Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 609 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. KuoLee, X. Zhao, J. Austin, G. Harris, J. W. Conlan, and W. Chen Mouse Model of Oral Infection with Virulent Type A Francisella tularensis Infect. Immun., April 1, 2007; 75(4): 1651 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakayama, D. M. Underhill, T. W. Petersen, B. Li, T. Kitamura, T. Takai, and A. Aderem Paired Ig-Like Receptors Bind to Bacteria and Shape TLR-Mediated Cytokine Production J. Immunol., April 1, 2007; 178(7): 4250 - 4259. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kielian, N. K. Phulwani, N. Esen, M. Md. Syed, A. C. Haney, K. McCastlain, and J. Johnson MyD88-Dependent Signals Are Essential for the Host Immune Response in Experimental Brain Abscess J. Immunol., April 1, 2007; 178(7): 4528 - 4537. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kapetanovic, M.-A. Nahori, V. Balloy, C. Fitting, D. J. Philpott, J.-M. Cavaillon, and M. Adib-Conquy Contribution of Phagocytosis and Intracellular Sensing for Cytokine Production by Staphylococcus aureus-Activated Macrophages Infect. Immun., February 1, 2007; 75(2): 830 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cao, A. Castrillo, P. Tontonoz, F. Re, and G. I. Byrne Chlamydia pneumoniae-Induced Macrophage Foam Cell Formation Is Mediated by Toll-Like Receptor 2 Infect. Immun., February 1, 2007; 75(2): 753 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Skerrett, C. B. Wilson, H. D. Liggitt, and A. M. Hajjar Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L312 - L322. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Hardarson, J. S. Baker, Z. Yang, E. Purevjav, C.-H. Huang, L. Alexopoulou, N. Li, R. A. Flavell, N. E. Bowles, and J. G. Vallejo Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H251 - H258. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Burns, G. Bachrach, L. Shapira, and G. Nussbaum Cutting Edge: TLR2 Is Required for the Innate Response to Porphyromonas gingivalis: Activation Leads to Bacterial Persistence and TLR2 Deficiency Attenuates Induced Alveolar Bone Resorption J. Immunol., December 15, 2006; 177(12): 8296 - 8300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, J. H. Weis, T. G. Schwan, and J. J. Weis Dual Role of MyD88 in Rapid Clearance of Relapsing Fever Borrelia spp. Infect. Immun., December 1, 2006; 74(12): 6750 - 6760. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Flacher, M. Bouschbacher, E. Verronese, C. Massacrier, V. Sisirak, O. Berthier-Vergnes, B. de Saint-Vis, C. Caux, C. Dezutter-Dambuyant, S. Lebecque, et al. Human Langerhans Cells Express a Specific TLR Profile and Differentially Respond to Viruses and Gram-Positive Bacteria J. Immunol., December 1, 2006; 177(11): 7959 - 7967. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Mullaly and P. Kubes The Role of TLR2 In Vivo following Challenge with Staphylococcus aureus and Prototypic Ligands J. Immunol., December 1, 2006; 177(11): 8154 - 8163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Buckley, J. H. Wang, and H. P. Redmond Cellular reprogramming by gram-positive bacterial components: a review J. Leukoc. Biol., October 1, 2006; 80(4): 731 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bubeck Wardenburg, W. A. Williams, and D. Missiakas Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins PNAS, September 12, 2006; 103(37): 13831 - 13836. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, A. G. Hise, C. M. Kalsow, and E. Pearlman Staphylococcus aureus-Induced Corneal Inflammation Is Dependent on Toll-Like Receptor 2 and Myeloid Differentiation Factor 88 Infect. Immun., September 1, 2006; 74(9): 5325 - 5332. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mikami, J. H. Lim, H. Ishinaga, U.-H. Ha, H. Gu, T. Koga, H. Jono, H. Kai, and J.-D. Li The Transforming Growth Factor-beta-Smad3/4 Signaling Pathway Acts as a Positive Regulator for TLR2 Induction by Bacteria via a Dual Mechanism Involving Functional Cooperation with NF-{kappa}B and MAPK Phosphatase 1-dependent Negative Cross-talk with p38 MAPK J. Biol. Chem., August 4, 2006; 281(31): 22397 - 22408. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsukuba, S. Yamamoto, M. Yanagawa, K. Okamoto, Y. Okamoto, K. I. Nakayama, T. Kadowaki, and K. Yamamoto Cathepsin e-deficient mice show increased susceptibility to bacterial infection associated with the decreased expression of multiple cell surface toll-like receptors. J. Biochem., July 1, 2006; 140(1): 57 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Archer and C. R. Roy MyD88-Dependent Responses Involving Toll-Like Receptor 2 Are Important for Protection and Clearance of Legionella pneumophila in a Mouse Model of Legionnaires' Disease. Infect. Immun., June 1, 2006; 74(6): 3325 - 3333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Romics Jr, G. Szabo, J. C. Coffey, J. H. Wang, and H. P. Redmond The Emerging Role of Toll-Like Receptor Pathways in Surgical Diseases Arch Surg, June 1, 2006; 141(6): 595 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Esen and T. Kielian Central Role for MyD88 in the Responses of Microglia to Pathogen-Associated Molecular Patterns. J. Immunol., June 1, 2006; 176(11): 6802 - 6811. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Katz, P. Zhang, M. Martin, S. N. Vogel, and S. M. Michalek Toll-Like Receptor 2 Is Required for Inflammatory Responses to Francisella tularensis LVS. Infect. Immun., May 1, 2006; 74(5): 2809 - 2816. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Szomolanyi-Tsuda, X. Liang, R. M. Welsh, E. A. Kurt-Jones, and R. W. Finberg Role for TLR2 in NK Cell-Mediated Control of Murine Cytomegalovirus In Vivo J. Virol., May 1, 2006; 80(9): 4286 - 4291. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. van der Sar, O. W. Stockhammer, C. van der Laan, H. P. Spaink, W. Bitter, and A. H. Meijer MyD88 Innate Immune Function in a Zebrafish Embryo Infection Model Infect. Immun., April 1, 2006; 74(4): 2436 - 2441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fan, Y. Li, Y. Vodovotz, T. R. Billiar, and M. A. Wilson Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L738 - L746. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Behera, E. Hildebrand, R. T. Bronson, G. Perides, S. Uematsu, S. Akira, and L. T. Hu MyD88 Deficiency Results in Tissue-Specific Changes in Cytokine Induction and Inflammation in Interleukin-18-Independent Mice Infected with Borrelia burgdorferi Infect. Immun., March 1, 2006; 74(3): 1462 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-T.A. Teng Protective and Destructive Immunity in the Periodontium: Part 1--Innate and Humoral Immunity and the Periodontium Journal of Dental Research, March 1, 2006; 85(3): 198 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Knapp, C. W. Wieland, S. Florquin, R. Pantophlet, L. Dijkshoorn, N. Tshimbalanga, S. Akira, and T. van der Poll Differential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 122 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshida, H. Jono, H. Kai, and J.-D. Li The Tumor Suppressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7 J. Biol. Chem., December 9, 2005; 280(49): 41111 - 41121. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Su, P. B. Silver, R. S. Grajewski, R. K. Agarwal, J. Tang, C.-C. Chan, and R. R. Caspi Essential Role of the MyD88 Pathway, but Nonessential Roles of TLRs 2, 4, and 9, in the Adjuvant Effect Promoting Th1-Mediated Autoimmunity J. Immunol., November 15, 2005; 175(10): 6303 - 6310. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kielian, A. Haney, P. M. Mayes, S. Garg, and N. Esen Toll-Like Receptor 2 Modulates the Proinflammatory Milieu in Staphylococcus aureus-Induced Brain Abscess Infect. Immun., November 1, 2005; 73(11): 7428 - 7435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hadley, J. E. Wang, S. J. Foster, C. Thiemermann, and C. J. Hinds Peptidoglycan of Staphylococcus aureus Upregulates Monocyte Expression of CD14, Toll-Like Receptor 2 (TLR2), and TLR4 in Human Blood: Possible Implications for Priming of Lipopolysaccharide Signaling Infect. Immun., November 1, 2005; 73(11): 7613 - 7619. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mikami, H. Gu, H. Jono, A. Andalibi, H. Kai, and J.-D. Li Epidermal Growth Factor Receptor Acts as a Negative Regulator for Bacterium Nontypeable Haemophilus influenzae-induced Toll-like Receptor 2 Expression via an Src-dependent p38 Mitogen-activated Protein Kinase Signaling Pathway J. Biol. Chem., October 28, 2005; 280(43): 36185 - 36194. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fuse, G. Chan, Y. Liu, P. Gudgeon, M. Husain, M. Chen, W.-C. Yeh, S. Akira, and P. P. Liu Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3-Induced Myocarditis and Influences Type I Interferon Production Circulation, October 11, 2005; 112(15): 2276 - 2285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Netea, J. W. M. Van der Meer, R. P. Sutmuller, G. J. Adema, and B.-J. Kullberg From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias Antimicrob. Agents Chemother., October 1, 2005; 49(10): 3991 - 3996. [Full Text] [PDF] |
||||
![]() |
A. Srivastava, P. Henneke, A. Visintin, S. C. Morse, V. Martin, C. Watkins, J. C. Paton, M. R. Wessels, D. T. Golenbock, and R. Malley The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal Disease Infect. Immun., October 1, 2005; 73(10): 6479 - 6487. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Balloy, M. Si-Tahar, O. Takeuchi, B. Philippe, M.-A. Nahori, M. Tanguy, M. Huerre, S. Akira, J.-P. Latge, and M. Chignard Involvement of Toll-Like Receptor 2 in Experimental Invasive Pulmonary Aspergillosis Infect. Immun., September 1, 2005; 73(9): 5420 - 5425. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Naiki, K. S. Michelsen, N. W. J. Schroder, R. Alsabeh, A. Slepenkin, W. Zhang, S. Chen, B. Wei, Y. Bulut, M. H. Wong, et al. MyD88 Is Pivotal for the Early Inflammatory Response and Subsequent Bacterial Clearance and Survival in a Mouse Model of Chlamydia pneumoniae Pneumonia J. Biol. Chem., August 12, 2005; 280(32): 29242 - 29249. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Mun, F. Aosai, K. Norose, L.-X. Piao, H. Fang, S. Akira, and A. Yano Toll-Like Receptor 4 Mediates Tolerance in Macrophages Stimulated with Toxoplasma gondii-Derived Heat Shock Protein 70 Infect. Immun., August 1, 2005; 73(8): 4634 - 4642. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fan, B. Zingarelli, O. M. Peck, G. Teti, G. E. Tempel, P. V. Halushka, and J. A. Cook Lipopolysaccharide- and gram-positive bacteria-induced cellular inflammatory responses: role of heterotrimeric G{alpha}i proteins Am J Physiol Cell Physiol, August 1, 2005; 289(2): C293 - C301. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fournier and D. J. Philpott Recognition of Staphylococcus aureus by the Innate Immune System Clin. Microbiol. Rev., July 1, 2005; 18(3): 521 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Omatsu, T. Iyoda, Y. Kimura, A. Maki, M. Ishimori, N. Toyama-Sorimachi, and K. Inaba Development of Murine Plasmacytoid Dendritic Cells Defined by Increased Expression of an Inhibitory NK Receptor, Ly49Q J. Immunol., June 1, 2005; 174(11): 6657 - 6662. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Henneke, S. Morath, S. Uematsu, S. Weichert, M. Pfitzenmaier, O. Takeuchi, A. Muller, C. Poyart, S. Akira, R. Berner, et al. Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus J. Immunol., May 15, 2005; 174(10): 6449 - 6455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Netea, G. Ferwerda, D. J. de Jong, T. Jansen, L. Jacobs, M. Kramer, T. H. J. Naber, J. P. H. Drenth, S. E. Girardin{paragraph}, B. Jan Kullberg, et al. Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release J. Immunol., May 15, 2005; 174(10): 6518 - 6523. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Chu, S. Jeyaseelan, J. G. Rino, D. R. Voelker, R. B. Wexler, K. Campbell, R. J. Harbeck, and R. J. Martin TLR2 Signaling Is Critical for Mycoplasma pneumoniae-Induced Airway Mucin Expression J. Immunol., May 1, 2005; 174(9): 5713 - 5719. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rodriguez, F. Fend, L. Jennen, M. Schiemann, N. Wantia, C. U. P. da Costa, S. Durr, U. Heinzmann, H. Wagner, and T. Miethke Polymorphonuclear Neutrophils Improve Replication of Chlamydia pneumoniae In Vivo upon MyD88-Dependent Attraction J. Immunol., April 15, 2005; 174(8): 4836 - 4844. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lorenz, D. C. Chemotti, A. L. Jiang, and L. D. McDougal Differential Involvement of Toll-Like Receptors 2 and 4 in the Host Response to Acute Respiratory Infections with Wild-Type and Mutant Haemophilus influenzae Strains Infect. Immun., April 1, 2005; 73(4): 2075 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Kau, S. M. Martin, W. Lyon, E. Hayes, M. G. Caparon, and S. J. Hultgren Enterococcus faecalis Tropism for the Kidneys in the Urinary Tract of C57BL/6J Mice Infect. Immun., April 1, 2005; 73(4): 2461 - 2468. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I Lancaster, Q. Khan, P. Drysdale, F. Wallace, A. E Jeukendrup, M. T Drayson, and M. Gleeson The physiological regulation of toll-like receptor expression and function in humans J. Physiol., March 15, 2005; 563(3): 945 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gonzalez-Zorn, J. P. M. Senna, L. Fiette, S. Shorte, A. Testard, M. Chignard, P. Courvalin, and C. Grillot-Courvalin Bacterial and Host Factors Implicated in Nasal Carriage of Methicillin-Resistant Staphylococcus aureus in Mice Infect. Immun., March 1, 2005; 73(3): 1847 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bjorkbacka, K. A. Fitzgerald, F. Huet, X. Li, J. A. Gregory, M. A. Lee, C. M. Ordija, N. E. Dowley, D. T. Golenbock, and M. W. Freeman The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades Physiol Genomics, February 7, 2005; 19(3): 319 - 330. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |